Vol. 7 (04) pp. 23-28 DOI: 10.21474/IJAR01/8785

EVALUATION OF INTERFERON- γ LEVEL IN ASTHMA PATIENTS.

and
  • MB ChB, MSc. (Immunological disease), A specialist physician, Al-Yarmouk Teaching Hospital.
  • MB ChB, DG&O, Gynecologist, Al-Yarmouk Teaching Hospital.
51 Downloads 104 Views
Crossref

Download Full Paper (PDF)

Abstract

Background: Bronchial asthma is a chronic inflammatory disease of the airways. It manifests with recurrent episodes of coughing, breathlessness, wheezing, and chest tightness. There is a noticeable increase in health care burden from asthma in several areas of the world. In asthmatic patients the reduced production of IFN-γ has been reported. Methodology: A total of 53 individuals were included in a comparative study. Full history was taken especially regarding the family history, disease presentation, in addition to careful physical examination. Serum IFN- γ assessment, WBC count, and Eosinophil count were measured. Results: The study covered 37 patients with bronchial asthma, and 16 apparently healthy individual as a control group. The highest rate 27% was in the age group of (20-29) year. There was no statistical significant difference between severity of asthma and residence of the patients (p=0.893). IFN- γ was significantly higher in those with bronchial asthma in comparison with control group (p=0.00001). Conclusion: All asthmatics have low serum IFN-γ level but high eosinophil count. Further detailed study of IFN-γ effectiveness in asthmatic patients, also carrying out a clinical trial about the use of IFN-γ in the treatment of asthma.Considering its role in treatment.

Keywords

Article Analytics

References

  1. Alimelu M, Radha M M, (2016). Asthma: environmental factors are major triggers in children - A teaching hospital experience. Journal of Dental and Medical Sciences (IOSR-JDMS); 15(6): 12-19. iosrjournals.org
  2. Aggarwal A N, Chaudhry K, Chhabra S K, D'Souza G A, Gupta D, Jindal S K, (2006), Prevalence and risk factors for bronchial asthma in Indian adults: a multicenter study. Indian J Chest Dis Allied Sci.; 48: 3-22
  3. Masoli M, Fabian D, Holt S, Beasley R. (2004), Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy; 59: 469-78.
  4. Qing Yang, Hairong Zhang, Dongjun Ma, Xiaofang Jiang, Li Gao. (2), Association of methylation and expression of IL-4 and IFN-γ in peripheral
  5. blood of asthmatic patients. Biomedical Research 2017; 28 (14): 6303-6307.
  6. Barnes PJ, Chung KF, Page CP. (1999), Inflammatory mediators of asthma: An update. Pharmacol Rev; 50(4): 515-96.
  7. MahajanS, and Mehta A A. (2006), Role of cytokines in pathophysiology of asthma. Iranian J. of Pharmacology & Therapeutics (IJPT); 5(1): 1-14
  8. Hayden C, Pereira E, Rye P, Palmer L, Gibson N, Palenque M, et al. (1997), Mutation screening of interferon-g (IFN-γ) as a candidate gene for asthma. ClinExp Allergy; 27: 1412-16.
  9. Aggarwal A N., Chaudhry K., Chhabra S K., D?Souza G A., Gupta D., Jindal S K., (2006), Prevalence and risk factors for bronchial asthma in Indian adults: A multicenter study.Indian J Chest Dis Allied Sci; 48: 13-22
  10. Galli S J, Kalesnikoff J, Grimbaldeston M A, Piliponsky A M, Williams C M, Tsai M. (2005), Mast cells as ?tunable? effector and immunoregulatory cells: recent advances. Annu Rev Immunol; 23: 749-86.
  11. Larche M, Robinson D S, Kay A B. (2003), The role of T lymphocytes in the pathogenesis of asthma. J Allergy ClinImmunol; 111(3): 450-63.
  12. Drazen J, Respiratory system, bronchial asthma. In: Goldman L. and Claude Bennet J, Cecil textbook of medicine. 21st edition, 2004, USA, W. B. Saunders Company. pp: 387-393
  13. Allen C.M, Jeffrey K.A, Peter B, Nicholas AB, Andrew W. B, David A. et al. Respiratory system. In: Davidson?s principle and practice of medicine. 19th edition, 1996. ChirchillLivingtone, pp: 513-517
  14. Shim C. S, Williams M. H. (1999). Pediatric asthma. Promoting best practice. Guide for managing asthma in children. American Academy of Allergy, asthma and immunology; 68: 11-13
  15. Braun-Fahrl?nder C., Gassner M., Grize L., Neu U., Sennhauser F H., Varonier H. S, et al., (1999). Prevalence of hay fever and allergic sensitization in farmer?s children and their peers living in the same rual community. Scarpol team. Swiss study on childhood allergy and Respiratory Symptoms with respect to Air pollution. ClinExp Allergy; 29: 28-34
  16. Von Ehrenstein O S, Von Mutius E, Illi S, Baumann L, Bohm O, Kries R., (2000). Reduced risk of hay fever and asthma among children of farmers. ClinExp Allergy; 30: 187-193.
  17. Downs S. H, Marks G. B, Mitakakis T Z, Leuppi JD, Car N G, Peat J K., (2001). Having lived in on a farm and protection against allergic disease in Australia. ClinExp Allergy; 31:570-575
  18. Klintberg B, Berglund N, Lilja G, Wickman M, van Hage-Hamsten M, (2001). Fewer allergic respiratory disorders among farmers? children in aclosed birth cohort form Sweden. EurRespir J; 17:1151-1157.
  19. Remes S T, Pekkanen J, Soininen L, Kajosaari M, Husman T, Koivikko A, (2002). Does heredity modify the association between farming and allergy in children? ActaPaediatr; 91:1163-1169.
  20. Parish W, and Luckhurst E, (1989]. Eosinophilia VI, spontaneous synthesis of chemokinetics, chemotactic, complement receptor-inducing activities for eosinophils by bronchial T Lymphocytes of asthmatic-bronchitic patients. Clin Allergy; 12:475-488. [Medline]
  21. Panday C M, Brateanu A, (2007). White blood cell dynamics in COPD and asthmatic patients treated with corticosteroid. Chest by American College of Chest Physicians; 27:2.

How to Cite This Article

Ahmed Saeed Abdul-Jabbar and Emad T. Ahmed. (2019); EVALUATION OF INTERFERON- γ LEVEL IN ASTHMA PATIENTS., Int. J. of Adv. Res., 7 (04), 23-28, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/8785

Corresponding Author

Emad T. Ahmed
Gynecologist Al-Yarmouk Teaching Hospital
Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.